The spectrum of disease manifestations in patients with common variable immunodeficiency disorders and partial antibody deficiency in a university hospital

Journal of Clinical Immunology

Volumn 32, Issue 5, 2012, Pages 907-921

  Maarschalk Ellerbroek, L J ^a   Hoepelman, A I M ^a   Van Montfrans, J M ^b   Ellerbroek, P M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Autoimmune disease; B lymphocyte; Clinical manifestations; Common variable immunodeficiency; Diagnostic delay; Flow cytometry; Gastrointestinal disease; Lymphoproliverative; Malignancy; Pulmonary disease; T lymphocyte

Indexed keywords

ANTIBIOTIC AGENT; IMMUNOGLOBULIN G;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; AUTOINFLAMMATORY DISEASE; BRONCHIECTASIS; CLINICAL FEATURE; COMMON VARIABLE IMMUNODEFICIENCY; DELAYED DIAGNOSIS; FEMALE; FOLLOW UP; HUMAN; HUMORAL IMMUNE DEFICIENCY; IMMUNOGLOBULIN G DEFICIENCY; IMMUNOPHENOTYPING; INFECTION; INFECTION PREVENTION; INFECTIOUS COMPLICATION; LUNG COMPLICATION; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SELECTIVE ANTIBODY DEFICIENCY WITH NORMAL IMMUNOGLOBULIN; SUBSTITUTION THERAPY;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; INFECTION; MALE; MIDDLE AGED; NETHERLANDS; YOUNG ADULT;

EID: 84866742077     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-012-9671-6     Document Type: Article

References (64)

1. Joshi AY, Iyer VN, Hagan JB, St Sauver JL, Boyce TG. Incidence and temporal trends of primary immunodeficiency: a population-based cohort study. Mayo Clin Proc. 2009; 84(1):16-22.
2. Park MA, Li JT, Hagan JB, Maddox DE, Abraham RS. Common variable immunodeficiency: a new look at an old disease. Lancet. 2008; 372(9637):489-502.
3. Castigli E, Geha RS. Molecular basis of common variable immunodeficiency. J Allergy Clin Immunol. 2006; 117(4):740-6.
4. van Zelm MC, Smet J, Adams B, Mascart F, Schandene L, Janssen F, et al. CD81 gene defect in humans disrupts CD19 complex formation and leads to antibody deficiency. J Clin Invest. 2010; 120(4):1265-74.
5. Kuijpers TW, Bende RJ, Baars PA, Grummels A, Derks IA, Dolman KM, et al. CD20 deficiency in humans results in impaired T cell-independent antibody responses. J Clin Invest. 2010; 120(1):214-22.
6. Thickett KM, Kumararatne DS, Banerjee AK, Dudley R, Stableforth DE. Common variable immune deficiency: respiratory manifestations, pulmonary function and high-resolution CT scan findings. QJM. 2002; 95(10):655-62.
7. Cunningham-Rundles C, Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol. 1999; 92(1):34-48.
8. Seymour B, Miles J, Haeney M. Primary antibody deficiency and diagnostic delay. J Clin Pathol. 2005; 58(5):546-7.
9. Chapel H, Lucas M, Lee M, Bjorkander J, Webster D, Grimbacher B, et al. Common variable immunodeficiency disorders: division into distinct clinical phenotypes. Blood. 2008; 112(2):277-86.
10. Blore J, Haeney MR. Primary antibody deficiency and diagnostic delay. BMJ. 1989; 298(6672):516-7.
11. Kainulainen L, Varpula M, Liippo K, Svedstrom E, Nikoskelainen J, Ruuskanen O. Pulmonary abnormalities in patients with primary hypogammaglobulinemia. J Allergy Clin Immunol. 1999; 104 (5):1031-6.
12. Johnston SL, Hill SJ, Lock RJ, Dwight JF, Unsworth DJ, Gompels MM. Echocardiographic abnormalities in primary antibody deficiency. Postgrad Med J. 2004; 80(942):214-8.
13. Wehr C, Kivioja T, Schmitt C, Ferry B, Witte T, Eren E, et al. The EUROclass trial: defining subgroups in common variable immunodeficiency. Blood. 2008; 111(1):77-85.
14. Mechanic LJ, Dikman S, Cunningham-Rundles C. Granulomatous disease in common variable immunodeficiency. Ann Intern Med. 1997; 127(8 Pt 1):613-7.
15. Cunningham-Rundles C. Autoimmune manifestations in common variable immunodeficiency. J Clin Immunol. 2008; 28 Suppl 1: S42-5.
16. Khodadad A, Aghamohammadi A, Parvaneh N, Rezaei N, Mahjoob F, Bashashati M, et al. Gastrointestinal manifestations in patients with common variable immunodeficiency. Dig Dis Sci. 2007; 52 (11):2977-83.
17. Kinlen LJ, Webster AD, Bird AG, Haile R, Peto J, Soothill JF, et al. Prospective study of cancer in patients with hypogammaglobu-linaemia. Lancet. 1985; 1(8423):263-6.
18. Cunningham-Rundles C, Siegal FP, Cunningham-Rundles S, Lieberman P. Incidence of cancer in 98 patients with common varied immunodeficiency. J Clin Immunol. 1987; 7(4):294-9.
19. Warnatz K, Denz A, Drager R, Braun M, Groth C, Wolff-Vorbeck G, et al. Severe deficiency of switched memory B cells (CD27(+) IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease. Blood. 2002; 99(5):1544-51.
20. Piqueras B, Lavenu-Bombled C, Galicier L, der Bergeron-van CF, Mouthon L, Chevret S, et al. Common variable immunodeficiency patient classification based on impaired B cell memory differentiation correlates with clinical aspects. J Clin Immunol. 2003; 23 (5):385-400.
21. Malphettes M, Gerard L, Carmagnat M, Mouillot G, Vince N, Boutboul D, et al. Late-onset combined immune deficiency: a subset of common variable immunodeficiency with severe T cell defect. Clin Infect Dis. 2009; 49(9):1329-38.
22. Giovannetti A, Pierdominici M, Mazzetta F, Marziali M, Renzi C, Mileo AM, et al. Unravelling the complexity of T cell abnormalities in common variable immunodeficiency. J Immunol. 2007; 178 (6):3932-43.
23. Shackelford PG, Granoff DM, Madassery JV, Scott MG, Nahm MH. Clinical and immunologic characteristics of healthy children with subnormal serum concentrations of IgG2. Pediatr Res. 1990; 27(1):16-21.
24. Kutukculer N, Gulez N. The outcome of patients with unclassified hypogammaglobulinemia in early childhood. Pediatr Allergy Immunol. 2009; 20(7):693-8.
25. Conley ME, Notarangelo LD, Etzioni A. Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol. 1999; 93(3):190-7.
26. Eijkhout HW, van der Meer JW, Kallenberg CG, Weening RS, van Dissel JT, Sanders LA, et al. The effect of two different dosages of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypogammaglobulinemia. A randomized, double-blind, multicenter crossover trial. Ann Intern Med. 2001; 135(3):165-74.
27. van Gent R, van Tilburg CM, Nibbelke EE, Otto SA, Gaiser JF, Janssens-Korpela PL, et al. Refined characterization and reference values of the pediatric T-and B-cell compartments. Clin Immunol. 2009; 133(1):95-107.
28. van de Ven, van de Corp, van Tilburg CM, Tesselaar K, van GR, Sanders EA, et al. Lymphocyte characteristics in children with common variable immunodeficiency. Clin Immunol 2010 Apr; 135(1):63-71.
29. Quinti I, Soresina A, Spadaro G, Martino S, Donnanno S, Agostini C, et al. Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency. J Clin Immunol. 2007; 27(3):308-16.
30. Aghamohammadi A, Farhoudi A, Moin M, Rezaei N, Kouhi A, Pourpak Z, et al. Clinical and immunological features of 65 Iranian patients with common variable immunodeficiency. Clin Diagn Lab Immunol. 2005; 12(7):825-32.
31. Martinez Garcia MA, de Rojas MD, Nauffal M, Munoz Pamplona MP, Compte TL, Macian V, et al. Respiratory disorders in common variable immunodeficiency. Respir Med. 2001; 95(3):191-5.
32. Aghamohammadi A, Moin M, Farhoudi A, Rezaei N, Pourpak Z, Movahedi M, et al. Efficacy of intravenous immunoglobulin on the prevention of pneumonia in patients with agamma-globulinemia. FEMS Immunol Med Microbiol. 2004; 40 (2):113-8.
33. Busse PJ, Razvi S, Cunningham-Rundles C. Efficacy of intravenous immunoglobulin in the prevention of pneumonia in patients with common variable immunodeficiency. J Allergy Clin Immunol. 2002; 109(6):1001-4.
34. Ochs HD, Fischer SH, Wedgwood RJ, Wara DW, Cowan MJ, Ammann AJ, et al. Comparison of high-dose and low-dose intravenous immunoglobulin therapy in patients with primary immunodeficiency diseases. Am J Med. 1984; 76(3A):78-82.
35. Pruzanski W, Sussman G, Dorian W, Van T, Ibanez D, Redelmeier D, Relationship of the dose of intravenous gammaglobulin to the prevention of infections in adults with common variable immunodeficiency. Inflammation. 1996; 20(4):353-9.
36. Pourpak Z, Aghamohammadi A, Sedighipour L, Farhoudi A, Movahedi M, Gharagozlou M, et al. Effect of regular intravenous immunoglobulin therapy on prevention of pneumonia in patients with common variable immunodeficiency. J Microbiol Immunol Infect. 2006; 39(2):114-20.
37. Sweinberg SK, Wodell RA, Grodofsky MP, Greene JM, Conley ME. Retrospective analysis of the incidence of pulmonary disease in hypogammaglobulinemia. J Allergy Clin Immunol. 1991; 88 (1):96-104.
38. Obregon RG, Lynch DA, Kaske T, Newell Jr JD, Kirkpatrick Jr CH. Radiologic findings of adult primary immunodeficiency disorders. Contribution of CT. Chest. 1994; 106(2):490-5.
39. Tanaka N, Kim JS, Bates CA, Brown KK, Cool CD, Newell JD, et al. Lung diseases in patients with common variable immunodeficiency: chest radiographic, and computed tomographic findings. J Comput Assist Tomogr. 2006; 30(5):828-38.
40. Busse PJ, Farzan S, Cunningham-Rundles C. Pulmonary complications of common variable immunodeficiency. Ann Allergy Asthma Immunol. 2007; 98(1):1-8.
41. Touw CM, van de Ven AA, de Jong PA, Terheggen-Lagro S, Beek E, Sanders EA, et al. Detection of pulmonary complications in common variable immunodeficiency. Pediatr Allergy Immunol. 2010; 21(5):793-805.
42. de Gracia J, Vendrell M, Alvarez A, Pallisa E, Rodrigo MJ, de la Rosa D, et al. Immunoglobulin therapy to control lung damage in patients with common variable immunodeficiency. Int Immuno-pharmacol. 2004; 4(6):745-53.
43. Kainulainen L, Nikoskelainen J, Ruuskanen O. Diagnostic findings in 95 Finnish patients with common variable immunodeficiency. J Clin Immunol. 2001; 21(2):145-9.
44. Bondioni MP, Duse M, Plebani A, Soresina A, Notarangelo LD, Berlucchi M, et al. Pulmonary and sinusal changes in 45 patients with primary immunodeficiencies: computed tomography evaluation. J Comput Assist Tomogr. 2007; 31(4):620-8.
45. Roifman CM, Lederman HM, Lavi S, Stein LD, Levison H, Gelfand EW. Benefit of intravenous IgG replacement in hypogam-maglobulinemic patients with chronic sinopulmonary disease. Am J Med. 1985; 79(2):171-4.
46. Roifman CM, Levison H, Gelfand EW. High-dose versus low-dose intravenous immunoglobulin in hypogammaglobulinaemia and chronic lung disease. Lancet. 1987; 1(8541):1075-7.
47. Williams P, White A, Wilson JA, Yap PL. Penetration of administered IgG into the maxillary sinus and long-term clinical effects of intravenous immunoglobulin replacement therapy on sinusitis in primary hypogammaglobulinaemia. Acta Otolaryngol. 1991; 111(3):550-5.
48. Oksenhendler E, Gerard L, Fieschi C, Malphettes M, Mouillot G, Jaussaud R, et al. Infections in 252 patients with common variable immunodeficiency. Clin Infect Dis. 2008; 46(10):1547-54.
49. Agarwal S, Mayer L. Gastrointestinal manifestations in primary immune disorders. Inflamm Bowel Dis. 2010; 16(4):703-11.
50. Spickett G, Prentice AG, Wallington T, Webster AD, Chapel H. Alopecia totalis and vitiligo in common variable immunodeficiency. Postgrad Med J. 1991; 67(785):291-4.
51. Kilic S, Ersoy F, Sanal O, Turkbay D, Tezcan I. Alopecia universalis in a patient with common variable immunodeficiency. Pediatr Dermatol. 1999; 16(4):305-7.
52. Ipp MM, Gelfand EW. Antibody deficiency and alopecia. J Pediatr. 1976; 89(5):728-31.
53. Hermaszewski RA, Webster AD. Primary hypogammaglobulinaemia: a survey of clinical manifestations and complications. Q J Med. 1993; 86(1):31-42.
54. Orange JS, Glessner JT, Resnick E, Sullivan KE, Lucas M, Ferry B, et al. Genome-wide association identifies diverse causes of common variable immunodeficiency. J Allergy Clin Immunol. 2011; 127(6):1360-7.
55. Alachkar H, Taubenheim N, Haeney MR, Durandy A, Arkwright PD. Memory switched B cell percentage and not serum immunoglobulin concentration is associated with clinical complications in children and adults with specific antibody deficiency and common variable immunodeficiency. Clin Immunol. 2006; 120 (3):310-8.
56. Yong PL, Orange JS, Sullivan KE. Pediatric common variable immunodeficiency: immunologic and phenotypic associations with switched memory B cells. Pediatr Allergy Immunol. 2010; 21(5):852-8.
57. Wright JJ, Wagner DK, Blaese RM, Hagengruber C, Waldmann TA, Fleisher TA. Characterization of common variable immunodeficiency: identification of a subset of patients with distinctive immuno-phenotypic and clinical features. Blood. 1990; 76(10):2046-51.
58. Jaffe JS, Strober W, Sneller MC. Functional abnormalities of CD8+ T cells define a unique subset of patients with common variable immunodeficiency. Blood. 1993; 82(1):192-201.
59. Fischer MB, Hauber I, Eggenbauer H, Thon V, Vogel E, Schaffer E, et al. A defect in the early phase of T-cell receptor-mediated T-cell activation in patients with common variable immunodeficiency. Blood. 1994; 84(12):4234-41.
60. Guazzi V, Aiuti F, Mezzaroma I, Mazzetta F, Andolfi G, Mortellaro A, et al. Assessment of thymic output in common variable immunodeficiency patients by evaluation of T cell receptor excision circles. Clin Exp Immunol. 2002; 129(2):346-53.
61. Popa V, Kim K, Heiner DC. IgG deficiency in adults with recurrent respiratory infections. Ann Allergy. 1993; 70(5):418-24.
62. Abrahamian F, Agrawal S, Gupta S. Immunological and clinical profile of adult patients with selective immunoglobulin subclass deficiency: response to intravenous immunoglobulin therapy. Clin Exp Immunol. 2010; 159(3):344-50.
63. Olinder-Nielsen AM, Granert C, Forsberg P, Friman V, Vietorisz A, Bjorkander J. Immunoglobulin prophylaxis in 350 adults with IgG subclass deficiency and recurrent respiratory tract infections: a long-term follow-up. Scand J Infect Dis. 2007; 39(1):44-50.
64. Herrod HG. Management of the patient with IgG subclass deficiency and/or selective antibody deficiency. Ann Allergy. 1993; 70 (1):3-8.